Biomedical Co. Gets Approval For Ch. 11 Auction In January

Eye disease treatment developer Clearside Biomedical on Friday got permission from a Delaware bankruptcy judge for a January auction of its assets after saying it had resolved objections from shareholders and...

Already a subscriber? Click here to view full article